Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Seattle Genetics, Inc."'
Novel Auristatins with High Bystander and Cytotoxic Activities in Drug Efflux-positive Tumor Models.
Autor:
Moquist PN; Seattle Genetics, Inc., Bothell, Washington. pmoquist@seagen.com., Bovee TD; Seattle Genetics, Inc., Bothell, Washington., Waight AB; Seattle Genetics, Inc., Bothell, Washington., Mitchell JA; Seattle Genetics, Inc., Bothell, Washington., Miyamoto JB; Seattle Genetics, Inc., Bothell, Washington., Mason ML; Seattle Genetics, Inc., Bothell, Washington., Emmerton KK; Seattle Genetics, Inc., Bothell, Washington., Stevens N; Seattle Genetics, Inc., Bothell, Washington., Balasubramanian C; Seattle Genetics, Inc., Bothell, Washington., Simmons JK; Seattle Genetics, Inc., Bothell, Washington., Lyon RP; Seattle Genetics, Inc., Bothell, Washington., Senter PD; Seattle Genetics, Inc., Bothell, Washington., Doronina SO; Seattle Genetics, Inc., Bothell, Washington.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Feb; Vol. 20 (2), pp. 320-328. Date of Electronic Publication: 2020 Dec 07.
Autor:
Courter JR; Seattle Genetics, Inc., 21823 30(th) Drive SE, Bothell, WA 98021, USA. Electronic address: JCourter@seagen.com., Hamilton JZ; Seattle Genetics, Inc., 21823 30(th) Drive SE, Bothell, WA 98021, USA., Hendrick NR; Seattle Genetics, Inc., 21823 30(th) Drive SE, Bothell, WA 98021, USA., Zaval M; Seattle Genetics, Inc., 21823 30(th) Drive SE, Bothell, WA 98021, USA., Waight AB; Seattle Genetics, Inc., 21823 30(th) Drive SE, Bothell, WA 98021, USA., Lyon RP; Seattle Genetics, Inc., 21823 30(th) Drive SE, Bothell, WA 98021, USA., Senter PD; Seattle Genetics, Inc., 21823 30(th) Drive SE, Bothell, WA 98021, USA., Jeffrey SC; Seattle Genetics, Inc., 21823 30(th) Drive SE, Bothell, WA 98021, USA., Burke PJ; Seattle Genetics, Inc., 21823 30(th) Drive SE, Bothell, WA 98021, USA. Electronic address: PBurke@seagen.com.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2020 Jul 15; Vol. 30 (14), pp. 127241. Date of Electronic Publication: 2020 May 05.
Autor:
Simmons JK; Seattle Genetics, Inc., 21823 30(th) Dr SE, Bothell, WA, USA. Electronic address: jsimmons@seagen.com., Burke PJ; Seattle Genetics, Inc., 21823 30(th) Dr SE, Bothell, WA, USA., Cochran JH; Seattle Genetics, Inc., 21823 30(th) Dr SE, Bothell, WA, USA., Pittman PG; Seattle Genetics, Inc., 21823 30(th) Dr SE, Bothell, WA, USA., Lyon RP; Seattle Genetics, Inc., 21823 30(th) Dr SE, Bothell, WA, USA.
Publikováno v:
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2020 Apr 01; Vol. 392, pp. 114932. Date of Electronic Publication: 2020 Feb 25.
Autor:
Wolenski FS; Drug Safety Research and Evaluation, Takeda Pharmaceuticals International Co., Cambridge, MA, USA., Xia CQ; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., 35 Landsdowne Street, Cambridge, MA, USA., Ma B; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., 35 Landsdowne Street, Cambridge, MA, USA., Han TH; Seattle Genetics Inc., Bothell, WA, USA., Shyu WC; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., 35 Landsdowne Street, Cambridge, MA, USA., Balani SK; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., 35 Landsdowne Street, Cambridge, MA, USA. suresh.balani@takeda.com.
Publikováno v:
European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2018 Jun; Vol. 43 (3), pp. 347-354.
Autor:
Li H; Seattle Genetics, Inc., Bothell, WA, USA., Han TH; Seattle Genetics, Inc., Bothell, WA, USA., Hunder NN; Seattle Genetics, Inc., Bothell, WA, USA., Jang G; Seattle Genetics, Inc., Bothell, WA, USA., Zhao B; Seattle Genetics, Inc., Bothell, WA, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2017 Sep; Vol. 57 (9), pp. 1148-1158. Date of Electronic Publication: 2017 May 17.
Autor:
Levengood MR; Seattle Genetics, Inc., 21823 30thDrive SE, Bothell, WA, USA., Zhang X; Seattle Genetics, Inc., 21823 30thDrive SE, Bothell, WA, USA., Hunter JH; Seattle Genetics, Inc., 21823 30thDrive SE, Bothell, WA, USA., Emmerton KK; Seattle Genetics, Inc., 21823 30thDrive SE, Bothell, WA, USA., Miyamoto JB; Seattle Genetics, Inc., 21823 30thDrive SE, Bothell, WA, USA., Lewis TS; Seattle Genetics, Inc., 21823 30thDrive SE, Bothell, WA, USA., Senter PD; Seattle Genetics, Inc., 21823 30thDrive SE, Bothell, WA, USA.
Publikováno v:
Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2017 Jan 16; Vol. 56 (3), pp. 733-737. Date of Electronic Publication: 2016 Dec 14.
Autor:
Burke PJ; Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington. pburke@seagen.com., Hamilton JZ; Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington., Jeffrey SC; Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington., Hunter JH; Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington., Doronina SO; Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington., Okeley NM; Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington., Miyamoto JB; Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington., Anderson ME; Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington., Stone IJ; Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington., Ulrich ML; Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington., Simmons JK; Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington., McKinney EE; Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington., Senter PD; Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington., Lyon RP; Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2017 Jan; Vol. 16 (1), pp. 116-123. Date of Electronic Publication: 2016 Nov 09.
Autor:
Mattie M; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California. mmattie@agensys.com., Raitano A; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Morrison K; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Morrison K; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., An Z; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Capo L; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Verlinsky A; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Leavitt M; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Ou J; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Nadell R; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Aviña H; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Guevara C; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Malik F; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Moser R; Seattle Genetics, Inc., Bothell, Washington., Duniho S; Seattle Genetics, Inc., Bothell, Washington., Coleman J; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Li Y; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Pereira DS; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Doñate F; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Joseph IB; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Challita-Eid P; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California., Benjamin D; Seattle Genetics, Inc., Bothell, Washington., Stover DR; Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, California.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2016 Nov; Vol. 15 (11), pp. 2679-2687. Date of Electronic Publication: 2016 Aug 22.
Autor:
Waight AB; Department of Protein Sciences, Seattle Genetics, Inc., Bothell, WA, United States of America., Bargsten K; Department of Biology and Chemistry, Laboratory of Biomolecular Research, Paul Scherrer Institut, Villigen PSI, Switzerland., Doronina S; Department of Protein Sciences, Seattle Genetics, Inc., Bothell, WA, United States of America., Steinmetz MO; Department of Biology and Chemistry, Laboratory of Biomolecular Research, Paul Scherrer Institut, Villigen PSI, Switzerland., Sussman D; Department of Protein Sciences, Seattle Genetics, Inc., Bothell, WA, United States of America., Prota AE; Department of Biology and Chemistry, Laboratory of Biomolecular Research, Paul Scherrer Institut, Villigen PSI, Switzerland.
Publikováno v:
PloS one [PLoS One] 2016 Aug 12; Vol. 11 (8), pp. e0160890. Date of Electronic Publication: 2016 Aug 12 (Print Publication: 2016).
Autor:
Coveler AL; Seattle Cancer Care Alliance, University of Washington, 825 Eastlake Ave E, Seattle, WA, 98109, USA. acoveler@u.washington.edu., Ko AH; Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA., Catenacci DV; University of Chicago, Chicago, IL, USA., Von Hoff D; TGen Clinical Research Service at Scottsdale Healthcare, Scottsdale, AZ, USA., Becerra C; Texas Oncology, Baylor Sammons Cancer Center, Dallas, TX, USA., Whiting NC; Seattle Genetics, Inc., Bothell, WA, USA., Yang J; Seattle Genetics, Inc., Bothell, WA, USA., Wolpin B; Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2016 Jun; Vol. 34 (3), pp. 319-28. Date of Electronic Publication: 2016 Mar 18.